UR-12947

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameUR-12947
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonistsFibrinogen receptors inhibitors
TargetsIntegrin alpha-IIb/beta-3Fibrinogen receptors
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUriach
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUriach
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A